---
figid: PMC3674381__cddis201367f7
figtitle: Model of XIAP as a switch between type I and type II signaling
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3674381
filename: cddis201367f7.jpg
figlink: /pmc/articles/PMC3674381/figure/fig7/
number: F7
caption: Model of XIAP as a switch between type I and type II signaling. See text
  for details. Mit A, Mithramycin A; BZM, bortezomib
papertitle: Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance
  in carcinoma by switching apoptosis signaling to a Bax/Bak-independent â€˜type I'
  mode.
reftext: B Gillissen, et al. Cell Death Dis. 2013 May;4(5):e643.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.944608
figid_alias: PMC3674381__F7
figtype: Figure
redirect_from: /figures/PMC3674381__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3674381__cddis201367f7.html
  '@type': Dataset
  description: Model of XIAP as a switch between type I and type II signaling. See
    text for details. Mit A, Mithramycin A; BZM, bortezomib
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFSF10
  - BID
  - BAX
  - DIABLO
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - XIAP
  - STING1
---
